Somatic ERBB4 mutations have been reported in various cancers [29–31], and studies attempting to assess the impacts of these mutations have suggested both oncogenic and tumor suppressor functions for ERBB4 [22, 23, 30–33]. This evidence concerns the gene ERBB4 and cancer.